Sign In
Buy CPRX
$31.49
+0 (+0%)
At Close: Jul 31, 2026
Catalyst Pharmaceuticals, Inc. (CPRX) Q3 2024 Earnings Call Transcript
10:34am, Thursday, 07'th Nov 2024
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX ) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants Richard Daly - President and Chief Executive Officer Michael Kalb - Chie
Catalyst Pharmaceuticals, Inc. (CPRX) Hit a 52 Week High, Can the Run Continue?
10:20am, Thursday, 07'th Nov 2024
Catalyst (CPRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Catalyst (CPRX) Reports Q3 Earnings: What Key Metrics Have to Say
07:00pm, Wednesday, 06'th Nov 2024
The headline numbers for Catalyst (CPRX) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street est
Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings and Revenue Estimates
06:26pm, Wednesday, 06'th Nov 2024
Catalyst Pharmaceutical (CPRX) came out with quarterly earnings of $0.57 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to loss of $0.24 per share a year ago.
Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update
04:12pm, Wednesday, 06'th Nov 2024
Reports Q3 2024 Total Revenues of $ 128.7 Million, Representing a 25.3 % YoY Increase
CPRX vs. STVN: Which Stock Is the Better Value Option?
12:45pm, Wednesday, 06'th Nov 2024
Investors with an interest in Medical - Drugs stocks have likely encountered both Catalyst Pharmaceutical (CPRX) and Stevanato Group (STVN). But which of these two companies is the best option for tho
Pick These 4 Solid Net Profit Margin Stocks to Boost Portfolio Return
10:05am, Monday, 28'th Oct 2024
Pick these four top-ranked stocks, VRT, LMB, ATAT and CPRX, with solid net profit margins to enhance your portfolio returns.
Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024
08:03am, Tuesday, 22'nd Oct 2024
The Company will Host a Conference Call and Webcast on Thursday, November 7, 2024, at 8:30 AM ET The Company will Host a Conference Call and Webcast on Thursday, November 7, 2024, at 8:30 AM ET
CPRX or STVN: Which Is the Better Value Stock Right Now?
12:45pm, Monday, 21'st Oct 2024
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Catalyst Pharmaceutical (CPRX) and Stevanato Group (STVN). But which of these two stocks presents investor
What Makes Catalyst (CPRX) a Good Fit for 'Trend Investing'
09:50am, Monday, 21'st Oct 2024
If you are looking for stocks that are well positioned to maintain their recent uptrend, Catalyst (CPRX) could be a great choice. It is one of the several stocks that passed through our "Recent Price
Unlock Your Portfolio Value With These 4 High Earnings Yield Stocks
10:19am, Monday, 14'th Oct 2024
Add value to your portfolio with high earnings yield stocks like GOLD, CPRX, ALGT and AMX amid market uncertainty.
Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts
08:03am, Tuesday, 08'th Oct 2024
CORAL GABLES, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "the Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,
New Strong Buy Stocks for October 8th
06:30am, Tuesday, 08'th Oct 2024
CPRX, HCI, DXC, CRAI and CRUS have been added to the Zacks Rank #1 (Strong Buy) List on October 8, 2024.
CPRX or STVN: Which Is the Better Value Stock Right Now?
12:41pm, Friday, 04'th Oct 2024
Investors interested in Medical - Drugs stocks are likely familiar with Catalyst Pharmaceutical (CPRX) and Stevanato Group (STVN). But which of these two stocks is more attractive to value investors?
Catalyst (CPRX) is on the Move, Here's Why the Trend Could be Sustainable
09:50am, Wednesday, 02'nd Oct 2024
If you are looking for stocks that are well positioned to maintain their recent uptrend, Catalyst (CPRX) could be a great choice. It is one of the several stocks that passed through our "Recent Price
